This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08018/identifier/chemspider/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08018/identifier/pdb/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08018/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08018/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08018/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08018
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB08018 n9:DB08018
dcterms:title
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE
adms:identifier
n6:24697467 n10:24798097 n12:99444489 n13:DB08018 n14:JI3
n3:IUPAC-Name
n4:271B55E3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B55E9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B55E8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B55E5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B55E6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B55E7-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B55E1-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B55E2-363D-11E5-9242-09173F13E4C5 n4:271B55DF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B55E0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B55EF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B55F0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B55EA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B55EB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B55ED-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B55EC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B55EE-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B55F4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B55F6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B55F7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B55F3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B55F2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B55F5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B55E4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B55F1-363D-11E5-9242-09173F13E4C5